{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T13:38:37Z","timestamp":1772113117302,"version":"3.50.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.vaccine.2021.11.065","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T17:18:15Z","timestamp":1638983895000},"page":"298-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evaluating public acceptability of a potential Lyme disease vaccine using a population-based, cross-sectional survey in high incidence areas of the United States"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4981-1053","authenticated-orcid":false,"given":"Sarah A.","family":"Hook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1140-170X","authenticated-orcid":false,"given":"AmberJean P.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara A.","family":"Niesobecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5553-1675","authenticated-orcid":false,"given":"James I.","family":"Meek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3563-2943","authenticated-orcid":false,"given":"Jenna K.H.","family":"Bjork","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin M.","family":"Kough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly S.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5153-7471","authenticated-orcid":false,"given":"Elizabeth K.","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather J.","family":"Rutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6343-6109","authenticated-orcid":false,"given":"Jennifer L.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5155-1580","authenticated-orcid":false,"given":"Jennifer L.","family":"Peel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3105-3530","authenticated-orcid":false,"given":"Brad J.","family":"Biggerstaff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison F.","family":"Hinckley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.vaccine.2021.11.065_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6622a1","article-title":"Surveillance for Lyme disease \u2013 United States, 2008\u20132015","volume":"66","author":"Schwartz","year":"2017","journal-title":"MMWR Surveill Summ"},{"issue":"17","key":"10.1016\/j.vaccine.2021.11.065_b0010","doi-asserted-by":"crossref","first-page":"496","DOI":"10.15585\/mmwr.mm6717e1","article-title":"Vital signs: trends in reported vectorborne disease cases \u2013 United States and Territories, 2004\u20132016","volume":"67","author":"Rosenberg","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2021.11.065_b0015","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3201\/eid2109.150417","article-title":"Incidence of clinician-diagnosed lyme disease, United States, 2005\u20132010","volume":"21","author":"Nelson","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2021.11.065_b0020","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/cid\/ciu397","article-title":"Lyme disease testing by large commercial laboratories in the United States","volume":"59","author":"Hinckley","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2021.11.065_b0025","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3201\/eid2702.202731","article-title":"Estimating the frequency of Lyme disease diagnoses, United States, 2010\u20132018","volume":"27","author":"Kugeler","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2021.11.065_b0030","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2021.11.065_b0035","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJM199208203270806","article-title":"Prevention of Lyme disease after tick bites. A cost-effectiveness analysis","volume":"327","author":"Magid","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.11.065_b0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-128-1-199801010-00007","article-title":"Test-treatment strategies for patients suspected of having Lyme disease: a cost-effectiveness analysis","volume":"128","author":"Nichol","year":"1998","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.vaccine.2021.11.065_b0045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3201\/eid0503.990302","article-title":"The cost effectiveness of vaccinating against Lyme disease","volume":"5","author":"Meltzer","year":"1999","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2021.11.065_b0050","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/cid\/civ735","article-title":"Long-term assessment of post-treatment symptoms in patients with culture-confirmed early Lyme disease","volume":"61","author":"Weitzner","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.11.065_b0055","unstructured":"CDC. Lyme disease charts and figures: historical data; 2019."},{"issue":"24","key":"10.1016\/j.vaccine.2021.11.065_b0060","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1056\/NEJMra021397","article-title":"How can we prevent Lyme disease?","volume":"348","author":"Hayes","year":"2003","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2021.11.065_b0065","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/cid\/ciz872","article-title":"Protective immunity and new vaccines for Lyme disease","volume":"70","author":"Gomes-Solecki","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"17-19","key":"10.1016\/j.vaccine.2021.11.065_b0070","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/S0264-410X(00)00520-X","article-title":"The prevention of Lyme disease with vaccine","volume":"19","author":"Poland","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.11.065_b0075","first-page":"1","article-title":"Recommendations for the use of Lyme disease vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"48","author":"ACIP","year":"1999","journal-title":"Morb Mortal Wkly Rep"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2021.11.065_b0080","doi-asserted-by":"crossref","first-page":"s247","DOI":"10.1093\/cid\/ciq115","article-title":"The Lyme disease vaccine\u2013a public health perspective","volume":"52","author":"Shen","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2021.11.065_b0085","doi-asserted-by":"crossref","first-page":"s271","DOI":"10.1093\/cid\/ciq119","article-title":"Correcting a public health fiasco: the need for a new vaccine against Lyme disease","volume":"52","author":"Plotkin","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2021.11.065_b0090","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMp1607146","article-title":"Need for a new Lyme disease vaccine","volume":"375","author":"Plotkin","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.11.065_b0095","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1468-0009.2012.00663.x","article-title":"The rise and fall of the lyme disease vaccines: a cautionary tale for risk interventions in American medicine and public health","volume":"90","author":"Aronowitz","year":"2012","journal-title":"Milbank Q"},{"issue":"11-12","key":"10.1016\/j.vaccine.2021.11.065_b0100","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0264-410X(01)00500-X","article-title":"Adverse event reports following vaccination for Lyme disease: December 1998-July 2000","volume":"20","author":"Lathrop","year":"2002","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2021.11.065_b0105","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/art.24418","article-title":"HLA type and immune response to Borrelia burgdorferi outer surface protein a in people in whom arthritis developed after Lyme disease vaccination","volume":"60","author":"Ball","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.065_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268806007096","article-title":"The Lyme vaccine: a cautionary tale","volume":"135","author":"Nigrovic","year":"2007","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2021.11.065_b0115","series-title":"Can a new Lyme disease vaccine overcome a history of distrust and failure?","author":"Flaherty","year":"2019"},{"key":"10.1016\/j.vaccine.2021.11.065_b0120","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/infdis\/jiy627","article-title":"Anti-OspA DNA-encoded monoclonal antibody prevents transmission of spirochetes in tick challenge providing sterilizing immunity in mice","volume":"219","author":"Wang","year":"2019","journal-title":"J Infect Dis."},{"issue":"2","key":"10.1016\/j.vaccine.2021.11.065_b0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/infdis\/jiw151","article-title":"Pre-exposure prophylaxis with OspA-specific human monoclonal antibodies protects mice against tick transmission of Lyme disease spirochetes","volume":"214","author":"Wang","year":"2016","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2021.11.065_b0130","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1586\/eri.11.63","article-title":"Chronic Lyme disease: the controversies and the science","volume":"9","author":"Lantos","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2021.11.065_b0135","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.vaccine.2012.11.092","article-title":"Correlates of high vaccination exemption rates among kindergartens","volume":"31","author":"Birnbaum","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2021.11.065_b0140","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1542\/peds.2007-0538","article-title":"Parents with doubts about vaccines: which vaccines and reasons why","volume":"122","author":"Gust","year":"2008","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.vaccine.2021.11.065_b0145","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.vaccine.2019.12.004","article-title":"Factors associated with perceptions of influenza vaccine safety and effectiveness among adults, United States, 2017\u20132018","volume":"38","author":"Lutz","year":"2020","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2021.11.065_b0150","doi-asserted-by":"crossref","first-page":"S391","DOI":"10.1016\/j.amepre.2015.06.009","article-title":"Vaccine hesitancy: causes, consequences, and a call to action","volume":"49","author":"Salmon","year":"2015","journal-title":"Am J Prev Med"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.065_b0155","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/poq\/nfn003","article-title":"A Comparison of address-based sampling (ABS) versus random-digit dialing (RDD) for general population surveys","volume":"72","author":"Link","year":"2008","journal-title":"Publ Opin Quart"},{"key":"10.1016\/j.vaccine.2021.11.065_b0160","series-title":"Survey research methods","author":"Fowler","year":"2014"},{"key":"10.1016\/j.vaccine.2021.11.065_b0165","unstructured":"CDC. Epi Info. In: CDC, editor. 7.2.2.2 ed2017."},{"issue":"6","key":"10.1016\/j.vaccine.2021.11.065_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ttbdis.2019.07.008","article-title":"Knowledge, attitudes, and behaviors regarding tick-borne disease prevention in endemic areas","volume":"10","author":"Niesobecki","year":"2019","journal-title":"Ticks Tick Borne Dis"},{"issue":"2014","key":"10.1016\/j.vaccine.2021.11.065_b0175","first-page":"1","article-title":"NCHS urban-rural classification scheme for counties","volume":"2","author":"Ingram","year":"2013","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.vaccine.2021.11.065_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v009.i08","article-title":"Analysis of complex survey samples","volume":"9","author":"Lumley","year":"2004","journal-title":"J Stat Softw"},{"key":"10.1016\/j.vaccine.2021.11.065_b0185","series-title":"Complex surveys: a guide to analysis using R","author":"Lumley","year":"2010"},{"key":"10.1016\/j.vaccine.2021.11.065_b0190","series-title":"Design and analysis (advanced series)","author":"Sampling","year":"2010"},{"key":"10.1016\/j.vaccine.2021.11.065_b0195","unstructured":"Sarndal C-E, Lundstrom S. Estimation in surveys with nonresponse. West Sussex PO19 8SQ, England: John Wiley & Sons, Ltd; 2005."},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.065_b0200","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2307\/1912352","article-title":"Sample selection bias as a specification error","volume":"47","author":"Heckman","year":"1979","journal-title":"Econometrica"},{"issue":"1-2","key":"10.1016\/j.vaccine.2021.11.065_b0205","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0304-4076(84)90074-5","article-title":"Tobit models: a survey","volume":"24","author":"Amemiya","year":"1984","journal-title":"J Econ"},{"key":"10.1016\/j.vaccine.2021.11.065_b0210","unstructured":"Toomet O, Henningsen A. Sample selection models in R: package sampleselection."},{"key":"10.1016\/j.vaccine.2021.11.065_b0215","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1214\/aos\/1176346391","article-title":"On Chi-squared tests for multiway contingency tables with cell proportions estimated from survey data","volume":"12","author":"Rao","year":"1984","journal-title":"Ann Stat"},{"key":"10.1016\/j.vaccine.2021.11.065_b0220","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"2","key":"10.1016\/j.vaccine.2021.11.065_b0225","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.vaccine.2021.11.065_b0230","doi-asserted-by":"crossref","unstructured":"Wickham H. tidyverse: easily install and load the 'Tidyverse'. R package version 1.2.1 ed; 2017.","DOI":"10.32614\/CRAN.package.tidyverse"},{"key":"10.1016\/j.vaccine.2021.11.065_b0235","unstructured":"Freedman GE. srvyr: 'dplyr'-like syntax for summary statistics of survey data. R package version 0.3.4 ed; 2019."},{"key":"10.1016\/j.vaccine.2021.11.065_b0240","unstructured":"Lumley T. Survey: analysis of complex survey samples R package version 3.35-1 ed; 2019."},{"key":"10.1016\/j.vaccine.2021.11.065_b0245","unstructured":"Long J. _jtools: analysis and presentation of social scientific data_. R package version 2.0.1 ed; 2019."},{"key":"10.1016\/j.vaccine.2021.11.065_b0250","unstructured":"Wei T, Simko V. R package \u201ccorrplot\u201d: visualization of a correlation matrix (Version 0.84). Version 0.84 ed; 2017."},{"key":"10.1016\/j.vaccine.2021.11.065_b0255","series-title":"An R companion to applied regression","author":"Fox","year":"2011"},{"issue":"9","key":"10.1016\/j.vaccine.2021.11.065_b0260","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3201\/eid2109.150301","article-title":"TickNET--A collaborative public health approach to tickborne disease surveillance and research","volume":"21","author":"Mead","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.065_b0265","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/000992280204100107","article-title":"Parental knowledge of and attitudes toward LYMErix (recombinant Osp\u2013a lyme vaccine)","volume":"41","author":"Barone","year":"2002","journal-title":"Clin Pediatr (Phila)"},{"issue":"6","key":"10.1016\/j.vaccine.2021.11.065_b0270","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4278\/0890-1171-20.6.379","article-title":"An evaluation of a Lyme disease prevention program in a working population","volume":"20","author":"Nolan","year":"2006","journal-title":"Am J Health Promot"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.065_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ttbdis.2020.101605","article-title":"Experiences with tick exposure, Lyme disease, and use of personal prevention methods for tick bites among members of the U.S. population, 2013\u20132015","volume":"12","author":"Nawrocki","year":"2021","journal-title":"Ticks Tick-borne Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.065_b0280","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1542\/peds.114.1.187","article-title":"Children who have received no vaccines: who are they and where do they live?","volume":"114","author":"Smith","year":"2004","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.vaccine.2021.11.065_b0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6611a1","article-title":"Surveillance of vaccination coverage among adult populations \u2013 United States, 2015","volume":"66","author":"Williams","year":"2017","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.vaccine.2021.11.065_b0290","first-page":"95","article-title":"Vaccination coverage among adults, excluding influenza vaccination \u2013 United States, 2013","volume":"64","author":"Williams","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2021.11.065_b0295","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/003335491012500408","article-title":"The association between intentional delay of vaccine administration and timely childhood vaccination coverage","volume":"125","author":"Smith","year":"2010","journal-title":"Public Health Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2021.11.065_b0300","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/archpedi.159.5.470","article-title":"Factors associated with refusal of childhood vaccines among parents of school-aged children: a case-control study","volume":"159","author":"Salmon","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"9","key":"10.1016\/j.vaccine.2021.11.065_b0305","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1080\/21645515.2020.1735226","article-title":"How health care providers should address vaccine hesitancy in the clinical setting: evidence for presumptive language in making a strong recommendation","volume":"16","author":"Jacobson","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"39","key":"10.1016\/j.vaccine.2021.11.065_b0310","doi-asserted-by":"crossref","first-page":"19214","DOI":"10.1073\/pnas.1913923116","article-title":"Inner workings: Lyme disease vaccines face familiar challenges, both societal and scientific","volume":"116","author":"Shaffer","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2021.11.065_b0315","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jpeds.2018.10.034","article-title":"Association of provider recommendation and human papillomavirus vaccination initiation among male adolescents aged 13\u201317 Years-United States","volume":"206","author":"Lu","year":"2019","journal-title":"J Pediatr"},{"issue":"12","key":"10.1016\/j.vaccine.2021.11.065_b0320","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.4161\/hv.25823","article-title":"Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines","volume":"9","author":"Gargano","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2021.11.065_b0325","doi-asserted-by":"crossref","first-page":"D66","DOI":"10.1016\/j.vaccine.2015.09.035","article-title":"Vaccine hesitancy: causes, consequences, and a call to action","volume":"33","author":"Salmon","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2021.11.065_b0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017713","article-title":"Factors affecting intention to receive and self-reported receipt of 2009 pandemic (H1N1) vaccine in Hong Kong: a longitudinal study","volume":"6","author":"Liao","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2021.11.065_b0335","doi-asserted-by":"crossref","first-page":"672","DOI":"10.2105\/AJPH.2011.300407","article-title":"Trends in risk perceptions and vaccination intentions: a longitudinal study of the first year of the H1N1 pandemic","volume":"102","author":"Gidengil","year":"2012","journal-title":"Am J Public Health"},{"issue":"7","key":"10.1016\/j.vaccine.2021.11.065_b0340","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1177\/0272989X15608379","article-title":"Inspecting the mechanism: a longitudinal analysis of socioeconomic status differences in perceived influenza risks, vaccination intentions, and vaccination behaviors during the 2009\u20132010 influenza pandemic","volume":"36","author":"Maurer","year":"2016","journal-title":"Med Decis Making"},{"key":"10.1016\/j.vaccine.2021.11.065_bib341","article-title":"Understanding consumer and clinician perceptions of a potential Lyme disease vaccine","author":"Devchand","year":"2021","journal-title":"Health Education Research"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21015401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21015401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:08:15Z","timestamp":1759403295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21015401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0264410X21015401"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.11.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating public acceptability of a potential Lyme disease vaccine using a population-based, cross-sectional survey in high incidence areas of the United States","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.11.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}